MICHELLE ORTMAN: Open Payments
NPI 1104888213 · BEAVERCREEK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $1,007 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $94 |
| GENZYME CORPORATION | 2 | $69 |
| ABBVIE INC. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Madrigal Pharmaceuticals | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $14 |
Products named: XIFAXAN, DUPIXENT, EOHILIA, REZDIFFRA, RINVOQ, SKYRIZI, TREMFYA, OMVOH.
Industry payments across OH — which companies pay providers there.
